June 13, 2013

NAI Senior Consultant, Jill E. Sackman, D.V.M., Ph.D., explores the opportunities for pharmaceutical R&D and market entry in Southeast Asia in the latest installment of her emerging markets series, featured in BioPharm International.

Jill provides insight and guidance regarding trends in regulatory harmonization and pharmacovigilance, reimbursement, and regional considerations across the ASEAN countries that directly influence successful market entry.

See her full length article, Navigating Emerging Markets – Southeast Asia, published June 2013.